At a glance
ClinicalIndex Comparison RecordN/ACompleted· 228 enrolled
Drug / intervention
Carboxymethylcellulose and Glycerin based artificial tear +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
In Brief
A clinical study evaluating Carboxymethylcellulose and Glycerin based artificial tear and Carboxymethylcellulose for Dry Eye Syndrome. Completed, enrolled 228 participants across 1 site.
Detailed Summary
This study will evaluate the safety and efficacy of a new artificial tear for the treatment of dry eye that may occur after LASIK surgery
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndrome
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2007
First PostedOct 2007
Primary CompletionJun 2008
TodayJul 2026
First PostedOct 16, 2007
Enrollment StartSep 1, 2007
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 18.7 years ago
Interventions
Carboxymethylcellulose and Glycerin based artificial teardrug
As directed by Investigator at the end of each study visit: 1 to 2 drops in each eye, 1 to 2 times a day up to every hour while awake
Carboxymethylcellulosedrug
As directed by Investigator at the end of each study visit: 1 to 2 drops in each eye, 1 to 2 times a day up to every hour while awake